03/09/2026
2026 is proving to be an exciting year for clinical research at Moyes Eye Center! The team attended two Investigator meetings in Dallas, TX for important scientific advancements in ophthalmology. At each meeting, study coordinators received essential protocol training and guidance for bringing these advancements to qualifying patients.
In February, Bausch & Lomb provided the attendees with historical, educational, and meaningful discussions about their past, current, and upcoming products for dry eye patients.
In March, Aurion Biotech presenters shared incredible stories about the work they’d done to bring injectable corneal treatments to patients in El Salvador. The fascinating science behind the ABA-3 study originated in Japan, where the treatment has already been approved and provided for at least 250 patients.
